Roma-Wilson MA, Pozzilli P. Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132]. J Diabetes Complications 2025 Dec 3:109230. doi: 10.1016/j.jdiacomp.2025.109230.
PMID: 41344971